[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Peripheral Blood Mononuclear Cells Market, By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits), By Application (Immunology, Infectious Disease, Hematology and Others), By Technique (Density Gradient Centrifugation Process, Leukapheresis), By Source (Human, Animals), By Region, Competition, Forecast & Opportunities, 2025

December 2020 | 168 pages | ID: G99BE879D336EN
TechSci Research

US$ 4,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global market for peripheral blood mononuclear cells (PBMC) was valued at USD 172.29 Million in 2019 and is projected to grow at a CAGR of 8.46% during 2020 - 2025. The PBMC are crucial to carry out the biology and pathology related studies as well as in clinical research. Besides, PBMCs are also utilized in research related to fatal diseases, immunology, vaccine development, etc. However, high cost of PBMCs related studies might act as a challenge for the adoption of technology, especially in developing economies.

The global peripheral blood mononuclear cells market is segmented based on product, application, technique, source, and region. The product segment is further divided into cryopreserved or frozen PBMC, cultured or fresh PBMC and peripheral blood mononuclear cell isolation & viability kits. As of 2019, the cryopreserved PBMC or the frozen PBMC segment held the dominant market share as they can be used for longer durations of time if stored carefully at lower temperatures.

Based on regional analysis, North America accounted for the largest market share in the year 2019, on the back of a number of pre-existing peripheral blood mononuclear cells-based companies in the region. The economy of the region is also rich enough, which makes it easier to carry out the complex and costly R&D procedures.

Major players operating in the global peripheral blood mononuclear cells market include Thermo Fisher Scientific Inc., Merck & Co., Inc., Corning Incorporate, Bio-Rad Laboratories, Inc., Cellero, LLC, Life Technologies (India) Pvt. Ltd., Cell Applications, Inc., DAPCEL, Inc., Creative Bioarray, iXCells Biotechnologies USA, LLC, Miltenyi Biotec B.V. & CO. KG, STEMCELL Technologies Inc., Precision Medicine Group, LLC., StemExpress, LLC, HemaCare Corporation, BioVision, Inc., BioLegend, Inc., BioIVT LLC, Biopredic International, Zen-Bio Inc., etc.

Years considered for this report:
  • Historical Years: 2015 - 2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021 - 2025
Objective of the Study:
  • To analyze and forecast the market size of global peripheral blood mononuclear cells market.
  • To classify and forecast global peripheral blood mononuclear cells market based on product, application, technique, source, and region.
  • To identify drivers and challenges for global peripheral blood mononuclear cells market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global peripheral blood mononuclear cells market.
  • To conduct pricing analysis for global peripheral blood mononuclear cells market.
  • To identify and analyze the profile of leading players operating in global peripheral blood mononuclear cells market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading market players across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the research organizations and companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the research organizations and companies, and presence of all major players across the globe.

TechSci Research calculated the market size of global peripheral blood mononuclear cells market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
  • Biotechnology and pharma companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to peripheral blood mononuclear cells
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as research organizations & companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global peripheral blood mononuclear cells market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
  • Market, By Product:
    • Cryopreserved or Frozen PBMC
    • Cultured or Fresh PBMC
    • Peripheral Blood Mononuclear Cell Isolation & Viability Kits
  • Market, By Application:
    • Immunology
    • Infectious disease
    • Hematology
    • Others
  • Market, By Technique:
    • Density gradient centrifugation process
    • Leukapheresis
  • Market, By Source:
    • Human
    • Animals
  • Market, By Region:
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Singapore
      • Australia
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
    • North America
      • United States
      • Mexico
      • Canada
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle east & Africa
      • South Africa
      • Saudi Arabia
      • UAE
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global peripheral blood mononuclear cells market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information
  • Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. IMPACT OF COVID-19 ON GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET

4. EXECUTIVE SUMMARY

5. VOICE OF CUSTOMER

5.1. By Type of Product
5.2. By Type of Technique
5.3. Type of Application for Which PBMCs Are Used
5.4. Factors Driving Market Growth

6. GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits)
  6.2.2. By Application (Immunology, Infectious disease, Hematology and others)
  6.2.3. By Technique (Density gradient centrifugation process, Leukapheresis)
  6.2.4. By Source (Human, Animals)
  6.2.5. By Company (2019)
  6.2.6. By Region
6.3. Product Market Map

7. ASIA-PACIFIC PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By Application
  7.2.3. By Technique
  7.2.4. By Source
  7.2.5. By Country
7.3. Asia-Pacific: Country Analysis
  7.3.1. China Peripheral Blood Mononuclear Cells Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By Application
      7.3.1.2.3. By Technique
      7.3.1.2.4. By Source
  7.3.2. India Peripheral Blood Mononuclear Cells Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product
      7.3.2.2.2. By Application
      7.3.2.2.3. By Technique
      7.3.2.2.4. By Source
  7.3.3. Japan Peripheral Blood Mononuclear Cells Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product
      7.3.3.2.2. By Application
      7.3.3.2.3. By Technique
      7.3.3.2.4. By Source
  7.3.4. South Korea Peripheral Blood Mononuclear Cells Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Product
      7.3.4.2.2. By Application
      7.3.4.2.3. By Technique
      7.3.4.2.4. By Source
  7.3.5. Singapore Peripheral Blood Mononuclear Cells Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Product
      7.3.5.2.2. By Application
      7.3.5.2.3. By Technique
      7.3.5.2.4. By Source
  7.3.6. Australia Peripheral Blood Mononuclear Cells Market Outlook
    7.3.6.1. Market Size & Forecast
      7.3.6.1.1. By Value
    7.3.6.2. Market Share & Forecast
      7.3.6.2.1. By Product
      7.3.6.2.2. By Application
      7.3.6.2.3. By Technique
      7.3.6.2.4. By Source

8. EUROPE PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK

8.1. Market Size & Forecast
8.2. Market Size & Forecast
  8.2.1. By Value
8.3. Market Share & Forecast
  8.3.1. By Product
  8.3.2. By Application
  8.3.3. By Technique
  8.3.4. By Source
  8.3.5. By Country
8.4. Europe: Country Analysis
  8.4.1. France Peripheral Blood Mononuclear Cells Market Outlook
    8.4.1.1. Market Size & Forecast
      8.4.1.1.1. By Value
    8.4.1.2. Market Share & Forecast
      8.4.1.2.1. By Product
      8.4.1.2.2. By Application
      8.4.1.2.3. By Technique
      8.4.1.2.4. By Source
  8.4.2. Germany Peripheral Blood Mononuclear Cells Market Outlook
    8.4.2.1. Market Size & Forecast
      8.4.2.1.1. By Value
    8.4.2.2. Market Share & Forecast
      8.4.2.2.1. By Product
      8.4.2.2.2. By Application
      8.4.2.2.3. By Technique
      8.4.2.2.4. By Source
  8.4.3. United Kingdom Peripheral Blood Mononuclear Cells Market Outlook
    8.4.3.1. Market Size & Forecast
      8.4.3.1.1. By Value
    8.4.3.2. Market Share & Forecast
      8.4.3.2.1. By Product
      8.4.3.2.2. By Application
      8.4.3.2.3. By Technique
      8.4.3.2.4. By Source
  8.4.4. Italy Peripheral Blood Mononuclear Cells Market Outlook
    8.4.4.1. Market Size & Forecast
      8.4.4.1.1. By Value
    8.4.4.2. Market Share & Forecast
      8.4.4.2.1. By Product
      8.4.4.2.2. By Application
      8.4.4.2.3. By Technique
      8.4.4.2.4. By Source

9. NORTH AMERICA PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK

9.1. Market Size & Forecast
9.2. Market Size & Forecast
  9.2.1. By Value
9.3. Market Share & Forecast
  9.3.1. By Product
  9.3.2. By Application
  9.3.3. By Technique
  9.3.4. By Source
  9.3.5. By Country
9.4. North America: Country Analysis
  9.4.1. United States Peripheral Blood Mononuclear Cells Market Outlook
    9.4.1.1. Market Size & Forecast
      9.4.1.1.1. By Value
    9.4.1.2. Market Share & Forecast
      9.4.1.2.1. By Product
      9.4.1.2.2. By Application
      9.4.1.2.3. By Technique
      9.4.1.2.4. By Source
  9.4.2. Mexico Peripheral Blood Mononuclear Cells Market Outlook
    9.4.2.1. Market Size & Forecast
      9.4.2.1.1. By Value
    9.4.2.2. Market Share & Forecast
      9.4.2.2.1. By Product
      9.4.2.2.2. By Application
      9.4.2.2.3. By Technique
      9.4.2.2.4. By Source
  9.4.3. Canada Peripheral Blood Mononuclear Cells Market Outlook
    9.4.3.1. Market Size & Forecast
      9.4.3.1.1. By Value
    9.4.3.2. Market Share & Forecast
      9.4.3.2.1. By Product
      9.4.3.2.2. By Application
      9.4.3.2.3. By Technique
      9.4.3.2.4. By Source

10. SOUTH AMERICA PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK

10.1. Market Size & Forecast
10.2. Market Size & Forecast
  10.2.1. By Value
10.3. Market Share & Forecast
  10.3.1. By Product
  10.3.2. By Application
  10.3.3. By Technique
  10.3.4. By Source
  10.3.5. By Country
10.4. South America: Country Analysis
  10.4.1. Brazil Peripheral Blood Mononuclear Cells Market Outlook
    10.4.1.1. Market Size & Forecast
      10.4.1.1.1. By Value
    10.4.1.2. Market Share & Forecast
      10.4.1.2.1. By Product
      10.4.1.2.2. By Application
      10.4.1.2.3. By Technique
      10.4.1.2.4. By Source
  10.4.2. Argentina Peripheral Blood Mononuclear Cells Market Outlook
    10.4.2.1. Market Size & Forecast
      10.4.2.1.1. By Value
    10.4.2.2. Market Share & Forecast
      10.4.2.2.1. By Product
      10.4.2.2.2. By Application
      10.4.2.2.3. By Technique
      10.4.2.2.4. By Source
  10.4.3. Colombia Peripheral Blood Mononuclear Cells Market Outlook
    10.4.3.1. Market Size & Forecast
      10.4.3.1.1. By Value
    10.4.3.2. Market Share & Forecast
      10.4.3.2.1. By Product
      10.4.3.2.2. By Application
      10.4.3.2.3. By Technique
      10.4.3.2.4. By Source

11. MIDDLE EAST AND AFRICA PERIPHERAL BLOOD MONONUCLEAR CELLS MARKET OUTLOOK

11.1. Market Size & Forecast
11.2. Market Size & Forecast
  11.2.1. By Value
11.3. Market Share & Forecast
  11.3.1. By Product
  11.3.2. By Application
  11.3.3. By Technique
  11.3.4. By Source
  11.3.5. By Country
11.4. MEA: Country Analysis
  11.4.1. South Africa Peripheral Blood Mononuclear Cells Market Outlook
    11.4.1.1. Market Size & Forecast
      11.4.1.1.1. By Value
    11.4.1.2. Market Share & Forecast
      11.4.1.2.1. By Product
      11.4.1.2.2. By Application
      11.4.1.2.3. By Technique
      11.4.1.2.4. By Source
  11.4.2. Saudi Arabia Peripheral Blood Mononuclear Cells Market Outlook
    11.4.2.1. Market Size & Forecast
      11.4.2.1.1. By Value
    11.4.2.2. Market Share & Forecast
      11.4.2.2.1. By Product
      11.4.2.2.2. By Application
      11.4.2.2.3. By Technique
      11.4.2.2.4. By Source
  11.4.3. UAE Peripheral Blood Mononuclear Cells Market Outlook
    11.4.3.1. Market Size & Forecast
      11.4.3.1.1. By Value
    11.4.3.2. Market Share & Forecast
      11.4.3.2.1. By Product
      11.4.3.2.2. By Application
      11.4.3.2.3. By Technique
      11.4.3.2.4. By Source

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. CLINICAL TRIALS

15. COMPETITIVE LANDSCAPE

15.1. Competition Outlook
15.2. Players Profiled (Leading Companies)
  15.2.1. Thermo Fisher Scientific Inc.
  15.2.2. Merck & Co., Inc.
  15.2.3. Corning Incorporate
  15.2.4. Bio-Rad Laboratories, Inc.
  15.2.5. Cellero, LLC
  15.2.6. Life Technologies (India) Pvt. Ltd.
  15.2.7. Cell Applications, Inc.
  15.2.8. DAPCEL, Inc.
  15.2.9. Creative Bioarray
  15.2.10. iXCells Biotechnologies USA, LLC
  15.2.11. Miltenyi Biotec B.V. & CO. KG
  15.2.12. STEMCELL Technologies Inc.
  15.2.13. Precision Medicine Group, LLC.
  15.2.14. StemExpress, LLC
  15.2.15. HemaCare Corporation
  15.2.16. BioVision, Inc.
  15.2.17. BioLegend, Inc.
  15.2.18. BioIVT LLC
  15.2.19. Biopredic International
  15.2.20. Zen-Bio Inc.

16. STRATEGIC RECOMMENDATION

17. ABOUT US & DISCLAIMER

LIST OF FIGURES

Figure 1: Global Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 2: Global Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 3: Global Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 4: Global Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 5: Global Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 6: Global Peripheral Blood Mononuclear Cells Market Share, By Company, By Value, 2019
Figure 7: Global Peripheral Blood Mononuclear Cells Market Share, By Region, By Value, 2019 & 2025F
Figure 8:
Global Peripheral Blood Mononuclear Cells Market Map, By Product - Market Size (USD Million) &
Growth Rate (%)
Figure 9:
Global Peripheral Blood Mononuclear Cells Market Map, By Application - Market Size (USD Million) &
Growth Rate (%)
Figure 10:
Global Peripheral Blood Mononuclear Cells Market Map, By Technique - Market Size (USD Million) &
Growth Rate (%)
Figure 11:
Global Peripheral Blood Mononuclear Cells Market Map, By Source - Market Size (USD Million) &
Growth Rate (%)
Figure 12:
Global Peripheral Blood Mononuclear Cells Market Map, By Region - Market Size (USD Million) &
Growth Rate (%)
Figure 13: North America Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 14: North America Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 15: North America Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 16: North America Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 17: North America Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 18: North America Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
Figure 19: United States Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 20: New Cancer Cases in United States, (%), 2019
Figure 21: United States Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 22: United States Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 23: United States Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 24: United States Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 25: Canada Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 26: Canada Hospital Establishments, By Region, 2019 (Units)
Figure 27: Canada Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 28: Canada Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 29: Canada Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 30: Canada Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 31: Mexico Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 32: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 33: Mexico Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 34: Mexico Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 35: Mexico Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 36: Mexico Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 37: Europe Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 38: Europe Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 39: Europe Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 40: Europe Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 41: Europe Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 42: Europe Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
Figure 43: Germany Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 44: New Cancer Cases in Germany, (%), 2019
Figure 45: Germany Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 46: Germany Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 47: Germany Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 48: Germany Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 49: France Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 50: France Healthcare Spending, By Value (USD Per Capita), 2015-2019
Figure 51: France Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 52: France Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 53: France Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 54: France Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 55: United Kingdom Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 56: New Cancer Cases in United Kingdom, (%), 2019
Figure 57: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 58: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 59: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 60: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 61: Italy Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 62: Italy Total Health Expenditure as a Share of GDP (%), 2015 - 2019
Figure 63: Italy Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 64: Italy Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 65: Italy Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 66: Italy Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 67: Asia-Pacific Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 68: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 69: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 70: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 71: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 72: Asia-Pacific Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
Figure 73: China Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 74: New Cancer Cases in China (%), 2019
Figure 75: China Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 76: China Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 77: China Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 78: China Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 79: Japan Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 80: Japan Total Health Expenditure as a Share of GDP (%), 2015 - 2019
Figure 81: Japan Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 82: Japan Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 83: Japan Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 84: Japan Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 85: India Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 86: Total Number of Hospitals in India, 2019
Figure 87: India Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 88: India Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 89: India Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 90: India Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 91: South Korea Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 92: New Cancer Cases in South Korea (%), 2019
Figure 93: South Korea Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 94: South Korea Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 95: South Korea Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 96: South Korea Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 97: Australia Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 98: % of Public and Private Hospitals in Australia, 2019
Figure 99: Australia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 100: Australia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 101: Australia Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 102: Australia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 103: Singapore Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 104: New Cancer Cases in Singapore (%), 2019
Figure 105: Singapore Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 106: Singapore Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 107: Singapore Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 108: Singapore Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 109: South America Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 110: South America Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 111: South America Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 112: South America Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 113: South America Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 114: South America Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
Figure 115: Brazil Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 116: Total Number of Hospitals in Brazil, 2015-2019s
Figure 117: Brazil Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 118: Brazil Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 119: Brazil Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 120: Brazil Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 121: Argentina Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 122: Argentina Health Expenditure (% of GDP), 2015-2019
Figure 123: Argentina Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 124: Argentina Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 125: Argentina Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 126: Argentina Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 127: Colombia Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 128: New Cancer Cases in Colombia (%), 2019
Figure 129: Colombia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 130: Colombia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 131: Colombia Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 132: Colombia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 133: Middle East & Africa Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 134:
Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Product, By Value,
2015-2025F
Figure 135:
Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Application, By Value,
2015-2025F
Figure 136:
Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value,
2015-2025F
Figure 137: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 138: Middle East and Africa Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
Figure 139: UAE Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 140: UAE Health Expenditure (% of GDP), 2015-2019
Figure 141: UAE Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 142: UAE Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 143: UAE Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 144: UAE Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 145: Saudi Arabia Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 146: Total Number of Hospitals in Saudi Arabia, 2015-2019
Figure 147: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 148: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 149: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 150: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 151: South Africa Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 152: South Africa Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 153: South Africa Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 154: South Africa Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 155: South Africa Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 156: South Africa Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F

COMPANIES MENTIONED

1. Thermo Fisher Scientific Inc.
2. Merck & Co. , Inc.
3. Corning Incorporate
4. Bio-Rad Laboratories, Inc.
5. Cellero, LLC
6. Life Technologies (India) Pvt. Ltd.
7. Cell Applications, Inc.
8. DAPCEL, Inc.
9. Creative Bioarray
10. iXCells Biotechnologies USA, LLC
11. Miltenyi Biotec B. V. & CO. KG
12. STEMCELL Technologies Inc.
13. Precision Medicine Group, LLC.
14. StemExpress, LLC
15. HemaCare Corporation
16. BioVision, Inc.
17. BioLegend, Inc.
18. BioIVT LLC
19. Biopredic International
20. Zen-Bio Inc.

More Publications

Need Help?

Ask a Question

Market Reports

All Categories